Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02612675 · ClinicalTrials.gov registry record · NA
Glycemic Response to Oral Nutrition Supplements
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT02612675: Completed NA study, sponsored by Société des Produits Nestlé (SPN).
NCT02612675 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02612675, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This will be a randomized, cross-over study of two oral nutrition supplements in individuals with Type 2 Diabetes.
Interventions
- OTHER ONS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-02 |
| Phase | NA |
What the finished NCT02612675 record still lists
NCT02612675 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which ONS is the first listed.
NCT02612675 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02612675 about?
NCT02612675 is a clinical study titled "Glycemic Response to Oral Nutrition Supplements". This will be a randomized, cross-over study of two oral nutrition supplements in individuals with Type 2 Diabetes.
What is the current status of trial NCT02612675?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2013-01. Estimated completion is 2013-02.
What interventions are being tested in trial NCT02612675?
The interventions under investigation include: ONS (OTHER).
Who is sponsoring clinical trial NCT02612675?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02612675's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia